We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8B
AUM Growth
+$1.89B
(+9%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
3,143
New
326
Increased
869
Reduced
968
Closed
274
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$125M |
| 2 |
Southwest Airlines
LUV
|
+$121M |
| 3 |
Lam Research
LRCX
|
+$101M |
| 4 |
DuPont de Nemours
DD
|
+$92.3M |
| 5 |
NetApp
NTAP
|
+$74.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$91.2M |
| 2 |
Tyson Foods
TSN
|
+$72.4M |
| 3 |
Merck
MRK
|
+$67.7M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$67.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.59% |
| 2 | Technology | 15.59% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 10.36% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Supernus Pharmaceuticals
SUPN
$2.68B
| $28.8M | 0.13% |
721,097
-352,238
| -33% | -$15.2M |
|
|
UMPQ
227
DELISTED
Umpqua Holdings Corp
UMPQ
| $28.5M | 0.12% |
1,460,324
-510,914
| -26% | -$9.31M |
|
228
Hasbro
HAS
$12.6B
| $28.3M | 0.12% |
290,160
+157,205
| +118% | +$15.9M |
|
229
Edison International
EIX
$30.7B
| $28.3M | 0.12% |
366,413
+782
| +0.2% | +$61.9K |
|
|
GPOR
230
DELISTED
Gulfport Energy Corp.
GPOR
| $28.2M | 0.12% |
1,969,134
+250,966
| +15% | +$3.26M |
|
231
Mettler-Toledo International
MTD
$26.8B
| $28.1M | 0.12% |
44,928
-1,400
| -3% | -$841K |
|
|
IDTI
232
DELISTED
Integrated Device Technology I
IDTI
| $28.1M | 0.12% |
1,055,984
-189,380
| -15% | -$4.81M |
|
233
US Commodity Index
USCI
$372M
| $28M | 0.12% |
699,143
-307,204
| -31% | -$12.1M |
|
234
Centene
CNC
$31.3B
| $27.8M | 0.12% |
575,598
+124,180
| +28% | +$5.35M |
|
235
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $27.8M | 0.12% |
574,201
+11,348
| +2% | +$536K |
|
236
Qualcomm
QCOM
$176B
| $27.7M | 0.12% |
535,164
+30,857
| +6% | +$1.63M |
|
237
iShares Core S&P 500 ETF
IVV
$876B
| $27.7M | 0.12% |
109,533
-3,388
| -3% | -$841K |
|
238
Lockheed Martin
LMT
$134B
| $27.6M | 0.12% |
88,855
-3,393
| -4% | -$1.01M |
|
|
BNY
239
Bank of New York Mellon
BNY
$108B
| $27.4M | 0.12% |
517,512
-80,840
| -14% | -$4.24M |
|
240
Agilent Technologies
A
$39.1B
| $27.4M | 0.12% |
426,578
-315,897
| -43% | -$19.7M |
|
241
Celanese
CE
$5.09B
| $27.3M | 0.12% |
261,895
-50,752
| -16% | -$4.99M |
|
242
KLA
KLAC
$275B
| $26.9M | 0.12% |
2,539,550
+2,430,300
| +2,225% | +$23.2M |
|
243
Hilltop Holdings
HTH
$2.29B
| $26.5M | 0.12% |
1,020,615
-325,590
| -24% | -$8.18M |
|
244
Synchrony
SYF
$23.7B
| $26.5M | 0.12% |
852,575
-93,838
| -10% | -$2.81M |
|
|
ESRX
245
DELISTED
Express Scripts Holding Company
ESRX
| $26.3M | 0.12% |
415,708
-1,080,414
| -72% | -$67.1M |
|
246
Electronic Arts
EA
$52.4B
| $26.2M | 0.11% |
221,891
-4,156
| -2% | -$481K |
|
247
Verizon
VZ
$194B
| $25.9M | 0.11% |
523,089
-16,474
| -3% | -$775K |
|
248
Bristol-Myers Squibb
BMY
$127B
| $25.6M | 0.11% |
401,144
+54,180
| +16% | +$3.16M |
|
249
IPG Photonics
IPGP
$3.89B
| $25.4M | 0.11% |
137,163
+135,668
| +9,075% | +$22.5M |
|
250
D.R. Horton
DHI
$41B
| $25.2M | 0.11% |
631,108
-62,087
| -9% | -$2.26M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Glenmede Trust held 3,143 positions worth $22.8B, up 9% from $20.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust's Q3 2017 filing shows 326 new, 869 increased, 968 reduced and 274 closed positions. Its largest new stake was Five Below: 1,137,870 shares worth $62.4M. The largest sale was Du Pont De Nemours E I, an estimated $91.2M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- Glenmede Trust's largest Q3 2017 buy was Five Below: 1,137,870 shares worth $62.4M.
- Glenmede Trust added most to Constellation Brands in Q3 2017, an estimated $125M increase.
- Glenmede Trust's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $72.4M.
- Glenmede Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $91.2M.
- Glenmede Trust's ten largest holdings make up 15% of its $22.8B portfolio in Q3 2017.
- Glenmede Trust opened 326 new positions and closed 274 in Q3 2017.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $22.8B.
Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.